A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 15 Dec 2014
At a glance
- Drugs Sonidegib (Primary)
- Indications Pancreatic cancer
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 11 Dec 2014 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 05 May 2014 Planned end date changed from 1 Nov 2014 to 1 Nov 2015 as reported by ClinicalTrials.gov.